3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
53
PTGX Quote, Financials, Valuation and Earnings
Last price:
$48.35
Seasonality move
:
13.71%
Day range:
$47.09 - $48.80
52-week range:
$24.22 - $60.60
Dividend yield:
0%
P/E ratio:
11.51x
P/S ratio:
7.04x
P/B ratio:
4.40x
Volume:
1.2M
Avg. volume:
1.4M
1-year change:
67.16%
Market cap:
$3B
Revenue:
$434.4M
EPS (TTM):
$4.20
Protagonist Therapeutics Number of Institutional Trades
Protagonist Therapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$8.1B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$5.5B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Protagonist Therapeutics Institutional Ownership
-
What Percentage Of PTGX Is Owned by Institutions?
-- of PTGX is owned by institutions.
-
How Many Institutions Own PTGX Shares?
Protagonist Therapeutics stock is owned by 538 institutional shareholders at this time.
-
Have Institutions Been Buying PTGX Stock?
Yes, institutions have bought 105.5M shares of PTGX in the last quarter.
-
Have Institutions Been Selling PTGX Stock?
Yes, institutions have sold 69.5M shares of PTGX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 14.04% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 3.13% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 6.81% over the past day.
